Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1151-1160 of 10934

Edit search filters
  1. ORAL AZ-3102 in Patients With GM2 Gangliosidosis or Niemann Pick Type C Disease

  2. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects

    Rochester, MN

  4. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes

    Rochester, MN

  5. Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

    Rochester, MN

  6. Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

    Jacksonville, FL, Rochester, MN

  7. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. ETHAN - ET for Male BC

    Rochester, MN

  10. Ulixertinib in People With Histiocytic Neoplasms

    Rochester, MN

.

Mayo Clinic Footer